- Mixed-phenotype acute leukemia treated with decitabine
-
Lee JY, Lee SM, Lee JY, Kim KH, Choi MY, Lee WS
- KMID: 2373819
- Korean J Intern Med.
- 2016 Mar;31(2):406-408.
- doi: 10.3904/kjim.2014.353
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
-
Park H, Chung H, Lee J, Jang J, Kim Y, Kim SJ, Kim JS, Min YH, Cheong JW
- KMID: 2374186
- Yonsei Med J.
- 2017 Jan;58(1):35-42.
- doi: 10.3349/ymj.2017.58.1.35
PURPOSE: Decitabine, a DNA hypomethylating agent, was recently approved for use in Korea for older adults with acute myeloid leukemia (AML) who are not candidates for standard chemotherapy. This study... -
- CITED
-
- Close
- SHARE
-
- Close
